Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Juvenile Dermatomyositis Derails Growth and Pubertal Development

Publish date:: September 30, 2019

Key clinical point: Children in early puberty during the active phase of juvenile dermatomyositis had the highest risk of growth failure.

Major finding: Growth failure occurred in 21% of girls and 15% of boys with juvenile dermatomyositis over the course of a 2-year study.

Study details: The data come from a longitudinal cohort study of 196 children with juvenile dermatomyositis.

Disclosures: The study was supported by the European Union, Helse Nord Research grants, and by IRCCS Istituto Giannina Gaslini. Five authors of the study reported financial relationships with pharmaceutical companies.

Citation:

Nordal E et al. Arthritis Care Res. 2019 Sep 10. doi: 10.1002/acr.24065.

This Week's Must Reads

PASDAS beats DAS28 in measuring psoriatic arthritis treat-to-target success,

Cardiac CT scans can be used for osteoporosis screening,

Children rarely transmit SARS-CoV-2 within households,

Inhaled treprostinil improves walk distance in patients with ILD-associated pulmonary hypertension,

Pulmonary function tests can’t substitute for high-resolution CT in early systemic sclerosis ILD screening,

Must Reads in Pediatrics

Children rarely transmit SARS-CoV-2 within households,

Elevated inflammation common in children’s severe COVID-19 disease,

COVID-19 complicates prescribing for children with inflammatory skin disease,

Immunotherapy, steroids had positive outcomes in COVID-19–associated multisystem inflammatory syndrome,